rs117848117

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_018117.12(WDR11):​c.1425G>A​(p.Pro475Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00302 in 1,613,770 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0023 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 17 hom. )

Consequence

WDR11
NM_018117.12 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.62

Publications

4 publications found
Variant links:
Genes affected
WDR11 (HGNC:13831): (WD repeat domain 11) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is located in the chromosome 10q25-26 region, which is frequently deleted in gliomas and tumors of other tissues, and is disrupted by the t(10;19) translocation rearrangement in glioblastoma cells. The gene location suggests that it is a candidate gene for the tumor suppressor locus. [provided by RefSeq, Jul 2008]
WDR11 Gene-Disease associations (from GenCC):
  • hypogonadotropic hypogonadism 14 with or without anosmia
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Illumina
  • intellectual developmental disorder, autosomal recessive 78
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hypogonadotropic hypogonadism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Kallmann syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 10-120871300-G-A is Benign according to our data. Variant chr10-120871300-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 437271.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.62 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00228 (346/151902) while in subpopulation NFE AF = 0.00374 (254/67958). AF 95% confidence interval is 0.00336. There are 0 homozygotes in GnomAd4. There are 163 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 17 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018117.12. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WDR11
NM_018117.12
MANE Select
c.1425G>Ap.Pro475Pro
synonymous
Exon 10 of 29NP_060587.8

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WDR11
ENST00000263461.11
TSL:1 MANE Select
c.1425G>Ap.Pro475Pro
synonymous
Exon 10 of 29ENSP00000263461.5
WDR11
ENST00000497136.6
TSL:1
n.544G>A
non_coding_transcript_exon
Exon 8 of 26ENSP00000474595.1
WDR11
ENST00000605543.5
TSL:2
n.232G>A
non_coding_transcript_exon
Exon 3 of 22ENSP00000475076.1

Frequencies

GnomAD3 genomes
AF:
0.00228
AC:
346
AN:
151792
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000605
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000853
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00468
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00374
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00275
AC:
692
AN:
251464
AF XY:
0.00263
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00374
Gnomad NFE exome
AF:
0.00513
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00310
AC:
4531
AN:
1461868
Hom.:
17
Cov.:
32
AF XY:
0.00297
AC XY:
2160
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33476
American (AMR)
AF:
0.000313
AC:
14
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00425
AC:
227
AN:
53410
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00372
AC:
4140
AN:
1112004
Other (OTH)
AF:
0.00227
AC:
137
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
253
507
760
1014
1267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00228
AC:
346
AN:
151902
Hom.:
0
Cov.:
32
AF XY:
0.00220
AC XY:
163
AN XY:
74232
show subpopulations
African (AFR)
AF:
0.000603
AC:
25
AN:
41456
American (AMR)
AF:
0.000852
AC:
13
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4818
European-Finnish (FIN)
AF:
0.00468
AC:
49
AN:
10464
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00374
AC:
254
AN:
67958
Other (OTH)
AF:
0.00190
AC:
4
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00305
Hom.:
0
Bravo
AF:
0.00181
EpiCase
AF:
0.00278
EpiControl
AF:
0.00284

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Aug 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

WDR11: BP4, BP7, BS2

Jan 12, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
May 12, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.69
DANN
Benign
0.40
PhyloP100
-1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117848117; hg19: chr10-122630812; COSMIC: COSV54791774; API